AML Incubator Congratulates Nominis on Winning 1st Prize at Mastercard's Europe-Wide Fintech Forum - and Redefining the Future of Crypto Compliance
Athens, Greece--(Newsfile Corp. - May 16, 2025) - AML Incubator, backs founders who rethink broken systems. AMLI congratulates their partner Nominis for winning 1st place at Mastercard's Europe-wide Fintech Forum 2025 - a powerful signal that the future of crypto compliance is being built now.
Snir Levi, founder and CEO of Nominis.io posing with the first prize trophy.
To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/11332/252369_5bbc5030e4285905_001full.jpg
Why this matters:
Most KYT tools are reactive - built for regulators, not startups.
Nominis flips the model: a proactive, API-first KYT & Blockchain Investigation platform built for crypto startups, yet trusted by law enforcement.
They help teams see what others miss - the full transaction story, not just source of funds. With Nominis, founders and compliance & risk teams get real-time context: on-chain signals, off-chain intelligence and behavior data - all working together to identify and stop what actually matters. Read more here.
What makes Nominis different:
Clarity over chaos - decision-ready alerts, not noise
Continuous wallet monitoring - not just onboarding scans
On-Chain, Off-chain, GeoInt & behavioral analysis - full-spectrum attribution
End-to-end case management - resolve faster, act sooner
API-first, automation-ready - made to scale with any stack
Nominis will now advance to the continental finals in Berlin - a spotlight on the most promising Fintech Companies on the continent.
AMLI has deployed Nominis internally and with its portfolio. It consistently uncovers threats legacy KYT tools miss - and gives crypto companies the speed and context they need to stay ahead of financial crime.
This is more than a win for Nominis. It's a signal that a smarter, startup-first era of crypto compliance is here.
About AML Incubator
AML Incubator backs bold startups solving the world's toughest financial crime challenges. From early traction to strategic scale, we help founders build, connect, and redefine the future of trust in finance.
Press Contact:
corp@nominis.iowww.nominis.iohttps://www.linkedin.com/company/nominisio
hello@amlincubator.comwww.amlincubator.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/252369
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
FOX Advertising Launches Enhanced Brand Storytelling Program with Strategic Investment in The Lighthouse
CANNES, France, June 16, 2025 /PRNewswire/ -- FOX Advertising announced today a strategic investment in The Lighthouse (part of the Whalar Group), the innovative studio and campus space designed specifically for Creators to collaborate and develop content. The investment will also support the launch of FOX's new IP development initiative aimed at fueling Creator-led franchises across its content portfolio. At a time when brands and media companies are seeking immersive, IP-first ecosystems that blend content, commerce and culture, this strategic investment will further strengthen FOX's commitment to Creator-powered innovation and content creation. "At FOX, we see the future of entertainment and advertising will be driven by bold culture-shaping IP," said Stephano Kim, Chief Strategy & Operations Officer, FOX Advertising. "Our investment in The Lighthouse signals our commitment to building original franchises with visionary Creators who are redefining storytelling and influencing culture in real time." Unveiled at the Cannes Lions International Festival of Creativity, FOX and The Lighthouse's future-forward strategic relationship together with the launch of FOX's new IP development initiative will bring together the art of storytelling, brand integration, and new media experiences and will give advertisers the opportunity to collaborate with Creators around brand sponsorships and advertising inventory tied to new properties, as well as access to a pipeline of Creator-led properties designed for maximum cultural relevance and creative impact. On this strategic investment, Jon Goss, President, The Lighthouse, said: "This partnership with FOX is a defining moment for The Lighthouse. We built this campus at the intersection of media, creativity, and culture, where the next generation of bold, Creator-led IP can be imagined and launched. Together with FOX, we're reimagining how creators and brands don't just show up in culture, they help shape it." This investment and the launch of FOX's new IP development initiative will be FOX's first steps in building lasting franchises powered by Creator vision, network scale and brand from the start. About Fox Corporation:Fox Corporation produces and distributes compelling news, sports, and entertainment content through its primary iconic domestic brands, including FOX News Media, FOX Sports, FOX Entertainment, FOX Television Stations and Tubi Media Group. These brands hold cultural significance with consumers and commercial importance for distributors and advertisers. The breadth and depth of our footprint allows us to deliver content that engages and informs audiences, develop deeper consumer relationships, and create more compelling product offerings. FOX maintains an impressive track record of news, sports, and entertainment industry success that shapes our strategy to capitalize on existing strengths and invest in new initiatives. For more information about Fox Corporation, please visit About The Lighthouse:The Lighthouse, part of Whalar Group, is the in-real-life (IRL) creative campus and studio playground for the Creator Generation. Offering Creators an IRL platform to Learn, Make, and Belong. With locations opening in Venice, CA (2024), Brooklyn, NY (2025), and London/EMEA (2026), the campuses are designed to empower and support career Creators and creative professionals, providing a dynamic environment explicitly tailored to their needs. Each campus features state-of-the-art, mixed-use content studios and hosts impactful programming that empowers members to collaborate, learn, and grow their businesses within a thriving community. The Lighthouse expands opportunities and creative capabilities, offering Creators a dedicated space to co-create, connect, and lead the businesses shaping creative culture. Learn more: Cautionary Statement Concerning Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "should," "likely," "anticipates," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook" and similar expressions are used to identify these forward-looking statements. These statements are based on FOX and The Lighthouse management's current expectations and beliefs and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements in this press release due to changes in economic, business, competitive, technological, strategic and/or regulatory factors and other factors affecting the operation of FOX and The Lighthouse's businesses, including the impact of COVID-19 and other widespread health emergencies or pandemics and measures to contain their spread. Statements in this press release speak only as of the date they were made, and neither FOX nor The Lighthouse undertakes any duty to update or release any revisions to any forward-looking statement made in this press release or to report any events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events or to conform such statements to actual results or changes in FOX or The Lighthouse's expectations, except as required by law. View original content to download multimedia: SOURCE Fox Corporation Sign in to access your portfolio
Yahoo
35 minutes ago
- Yahoo
EU pushes back proposals to curb reliance on Russian nuclear fuel
By Kate Abnett LUXEMBOURG (Reuters) -The European Commission will not propose measures to limit the EU's reliance on Russian nuclear fuel this week alongside its proposals to ban Russian gas, EU energy commissioner Dan Jorgensen said on Monday. The Commission is due to propose legal measures this week to end the EU's Russian gas imports by the end of 2027 - an aim the EU executive announced last month. The Commission had said it would also propose, in June, trade measures targeting enriched uranium, to make imports from Russia less attractive and encourage countries to switch to other suppliers. "That will also come, but in the first stage, we'll be focusing on the gas," Jorgensen told reporters on Monday, when asked about the timing of the nuclear proposals. He did not specify a new date for the proposals. "The question about nuclear is, of course, complicated, because we need to be very sure that we are not putting countries in a situation where they do not have the security of supply. So we're working as fast as we can to also make that a part of the proposal," Jorgensen said. Russia supplied 38% of the EU's enriched uranium and 23% of its raw uranium in 2023, according to the think-tank Bruegel. The Commission has said it would also propose restricting new supply contracts for Russian uranium and enriched uranium which are co-signed by the Euratom Supply Agency. While Brussels has fixed an end-2027 deadline by which it aims to quit Russian gas, it has not indicated a date by which the EU should quit Russian nuclear supplies, owing to the complexity of countries' reliance on Russia for fuel, spare parts, or fuel cycle services - and the risk to security of supply if these were suddenly severed. The EU spent 23 billion euros ($26.63 billion) on Russian energy in 2024, of which around 1 billion euros was for nuclear fuel, the Commission has said. Five EU countries - Bulgaria, the Czech Republic, Finland, Hungary and Slovakia - have Russian-designed reactors set up to run on Russian fuel. While all except for Hungary have signed contracts for alternative supplies since 2022, years-long wait times mean they are not able to immediately switch. ($1 = 0.8636 euros) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
35 minutes ago
- Forbes
Is Insmed Stock Overvalued After The 45% Jump?
POLAND - 2025/01/18: In this photo illustration, the Insmed company logo is seen displayed on a ... More smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images) Insmed Inc (NASDAQ: INSM) was nothing short of a powerhouse last month, soaring 45%, while the S&P 500 index rose 3% in the same timeframe. What's driving this surge? Insmed revealed that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonary arterial hypertension (PAH) achieved both its primary and all secondary endpoints. Industry reports described the product as a 'home run' in contrast to competitors like United Therapeutics (NASDAQ: UTHR), which experienced an 11% decline over the last month. However, there's a caveat: Insmed is trading at 35 times sales. Turn that around, and you arrive at a meager 2.8% sales yield. In comparison, United Therapeutics—yes, the company with multiple FDA-approved drugs targeting PAH—trades at a lower sales multiple of 5 times and is generating operating profits of nearly 50%, in stark contrast to the losses reported by Insmed. So, while Insmed has achieved a significant medical breakthrough, at $98 per share, this represents a premium valuation pursuing an unproven growth narrative. When the anticipated growth fails to materialize, that's when reality strikes. Check Buy or Sell Insmed stock? Moreover, history tells a more complex story about Insmed stock. During the 2008 global financial crisis, its shares plummeted by nearly 78%. In the early days of the Covid pandemic in 2020, they fell by 60%. Then in 2022, with escalating inflation and consumer pressure, the stock stumbled again with a 63% drop. It's hardly invulnerable—yet today, the stock is trading at a premium valuation. Insmed's stock premium is mainly driven by the impressive Phase 2b trial results of its inhaled therapy TPIP for pulmonary arterial hypertension (PAH), which surpassed expectations and positions it as a possible best-in-class treatment. This clinical achievement, alongside a $750 million capital raise to facilitate pipeline expansion, has ignited investor optimism, causing the stock to rise significantly above its fair value estimates. Support from major institutions and strong revenue growth contribute to the bullish outlook, though its high valuation—trading at over 35 times price-to-sales—means that continued execution and progress toward Phase 3 trials will be vital for maintaining this momentum. Insmed projects global revenues for ARIKAYCE in 2025 to be between $405 million and $425 million, reflecting growth of 11–17% compared to 2024. Ongoing research and development investments for pipeline products (brensocatib, TPIP) mean that Insmed is expected to remain unprofitable into 2026. In the short term, the FDA's decision on brensocatib in August could significantly impact the stock. Additionally, the launch of Phase 3 trials for TPIP and further clinical updates will act as critical validation benchmarks. In the long run, successful execution during Phase 3 and eventual commercial launches of both brensocatib and TPIP will be key in determining whether INSM can uphold its current premium valuation. Insmed's surge reflects a combination of strong clinical progress, positive investor sentiment, and a solid financial path. However, the elevated valuation (P/S ~35×) signifies that upcoming milestones—such as the design and initiation of Phase 3 trials—will be essential in justifying this premium. Without these achievements, the stock may encounter pullbacks or merely sideways movement. Investing in a single stock carries inherent risks. Conversely, the Trefis High Quality (HQ) Portfolio, which comprises 30 stocks, has a history of comfortably outperforming the S&P 500 over the past 4-year period. Why is that? As a group, HQ Portfolio stocks have delivered superior returns with lower risk compared to the benchmark index, presenting a less volatile experience as demonstrated in HQ Portfolio performance metrics.
